The Efficacy and Safety of Temporal Interference Stimulation in the Treatment of Post-Traumatic Stress Disorder
Key facts
- Who runs it
- Shanghai Mental Health Center
- Where
- China1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Recruiting
- People taking part
- 5 people, planned
- Started
- 8 Jun 2026
- Expected to end
- Jun 2027
- Type of study
- Interventional
- Treatments tested
- TI stimulation device (nerviox-1000)
- Record updated
- 12 June 2026
Who can take part
- Age
- 18 years to 50 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 14 criteriaShow less
Who can take part
- Age 18-50 years, male or female
- Diagnosis of PTSD per DSM-5 (assessed by CAPS-5), with symptom duration of at least 3 months, and PTSD as the current primary diagnosis; comorbid depressive disorder or anxiety disorder is allowed
- If currently receiving psychiatric medication, the dosage must be stable for at least 4 weeks prior to enrollment
- At least 9 years of education (junior high school or above)
Who cannot take part
- Received electroconvulsive therapy (ECT) within the past 6 months
- Received any other form of neuromodulation within the past 2 months (see Item 3 for ECT)
- Initiation of structured psychotherapy for PTSD within 3 months prior to screening, with expected change during the 10-week treatment period
- Any DSM-5 diagnosis other than PTSD, depressive disorder, or anxiety disorder
- Severe medical illness or any condition that may induce seizures or intracranial hypertension (e.g., cardiovascular or respiratory diseases)
- History of neurological disorders (e.g., epilepsy, cerebrovascular accident) or brain injury/surgery
- Presence of intracranial stents, cardiac pacemakers, coronary stents, cochlear implants, or any other MRI-incompatible implants
- PTSD symptoms too severe to complete required assessments
- Current significant suicidal behavior risk per investigator judgment
- Pregnancy or planning to become pregnant during the study period
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 50 years old?
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This study aims to evaluate the efficacy and safety of Temporal Interference (TI) stimulation in treating patients with post-traumatic stress disorder (PTSD) and to explore its potential neural mechanisms using magnetic resonance imaging (MRI) ,magnetoencephalography(MEG),electroencephalography (EEG).
The group in the trial
- Bilateral Amygdala Group (BLA-TI)Treatment being tested
Open-label, single-arm. Participants receive active Temporal Interference (TI) stimulation targeting the bilateral amygdala. Stimulation is delivered twice daily (20 minutes per session) for 7 consecutive days. Parameters: carrier frequencies 2000 Hz and 2160 Hz, envelope frequency 160 Hz, intensity 3-4 mA (adjusted to individual tolerance). Target localization is performed using each participant's MRI data to construct an individualized 3D head model, generating scalp stimulation coordinates for the bilateral amygdala.
Treatment: TI stimulation device (nerviox-1000)
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorSaves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Fit questions
- Built from NCT07644338, who can take part
- Record updated
- 12 June 2026